Cargando…

Quantum dots in axillary lymph node mapping: Biodistribution study in healthy mice

BACKGROUND: Breast cancer is the first cause of cancer death among women and its incidence doubled in the last two decades. Several approaches for the treatment of these cancers have been developed. The axillary lymph node dissection (ALND) leads to numerous morbidity complications and is now advant...

Descripción completa

Detalles Bibliográficos
Autores principales: Robe, Anne, Pic, Emilie, Lassalle, Henri-Pierre, Bezdetnaya, Lina, Guillemin, François, Marchal, Frédéric
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375898/
https://www.ncbi.nlm.nih.gov/pubmed/18430208
http://dx.doi.org/10.1186/1471-2407-8-111
_version_ 1782154670154711040
author Robe, Anne
Pic, Emilie
Lassalle, Henri-Pierre
Bezdetnaya, Lina
Guillemin, François
Marchal, Frédéric
author_facet Robe, Anne
Pic, Emilie
Lassalle, Henri-Pierre
Bezdetnaya, Lina
Guillemin, François
Marchal, Frédéric
author_sort Robe, Anne
collection PubMed
description BACKGROUND: Breast cancer is the first cause of cancer death among women and its incidence doubled in the last two decades. Several approaches for the treatment of these cancers have been developed. The axillary lymph node dissection (ALND) leads to numerous morbidity complications and is now advantageously replaced by the dissection and the biopsy of the sentinel lymph node. Although this approach has strong advantages, it has its own limitations which are manipulation of radioactive products and possible anaphylactic reactions to the dye. As recently proposed, these limitations could in principle be by-passed if semiconductor nanoparticles (quantum dots or QDs) were used as fluorescent contrast agents for the in vivo imaging of SLN. QDs are fluorescent nanoparticles with unique optical properties like strong resistance to photobleaching, size dependent emission wavelength, large molar extinction coefficient, and good quantum yield. METHODS: CdSe/ZnS core/shell QDs emitting around 655 nm were used in our studies. 20 μL of 1 μM (20 pmol) QDs solution were injected subcutaneously in the anterior paw of healthy nude mice and the axillary lymph node (ALN) was identified visually after injection of a blue dye. In vivo fluorescence spectroscopy was performed on ALN before the mice were sacrificed at 5, 15, 30, 60 min and 24 h after QDs injection. ALN and all other organs were removed, cryosectioned and observed in fluorescence microscopy. The organs were then chemically made soluble to extract QDs. Plasmatic, urinary and fecal fluorescence levels were measured. RESULTS: QDs were detected in ALN as soon as 5 min and up to 24 h after the injection. The maximum amount of QDs in the ALN was detected 60 min after the injection and corresponds to 2.42% of the injected dose. Most of the injected QDs remained at the injection site. No QDs were detected in other tissues, plasma, urine and feces. CONCLUSION: Effective and rapid (few minutes) detection of sentinel lymph node using fluorescent imaging of quantum dots was demonstrated. This work was done using very low doses of injected QDs and the detection was done using a minimally invasive method.
format Text
id pubmed-2375898
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-23758982008-05-10 Quantum dots in axillary lymph node mapping: Biodistribution study in healthy mice Robe, Anne Pic, Emilie Lassalle, Henri-Pierre Bezdetnaya, Lina Guillemin, François Marchal, Frédéric BMC Cancer Research Article BACKGROUND: Breast cancer is the first cause of cancer death among women and its incidence doubled in the last two decades. Several approaches for the treatment of these cancers have been developed. The axillary lymph node dissection (ALND) leads to numerous morbidity complications and is now advantageously replaced by the dissection and the biopsy of the sentinel lymph node. Although this approach has strong advantages, it has its own limitations which are manipulation of radioactive products and possible anaphylactic reactions to the dye. As recently proposed, these limitations could in principle be by-passed if semiconductor nanoparticles (quantum dots or QDs) were used as fluorescent contrast agents for the in vivo imaging of SLN. QDs are fluorescent nanoparticles with unique optical properties like strong resistance to photobleaching, size dependent emission wavelength, large molar extinction coefficient, and good quantum yield. METHODS: CdSe/ZnS core/shell QDs emitting around 655 nm were used in our studies. 20 μL of 1 μM (20 pmol) QDs solution were injected subcutaneously in the anterior paw of healthy nude mice and the axillary lymph node (ALN) was identified visually after injection of a blue dye. In vivo fluorescence spectroscopy was performed on ALN before the mice were sacrificed at 5, 15, 30, 60 min and 24 h after QDs injection. ALN and all other organs were removed, cryosectioned and observed in fluorescence microscopy. The organs were then chemically made soluble to extract QDs. Plasmatic, urinary and fecal fluorescence levels were measured. RESULTS: QDs were detected in ALN as soon as 5 min and up to 24 h after the injection. The maximum amount of QDs in the ALN was detected 60 min after the injection and corresponds to 2.42% of the injected dose. Most of the injected QDs remained at the injection site. No QDs were detected in other tissues, plasma, urine and feces. CONCLUSION: Effective and rapid (few minutes) detection of sentinel lymph node using fluorescent imaging of quantum dots was demonstrated. This work was done using very low doses of injected QDs and the detection was done using a minimally invasive method. BioMed Central 2008-04-22 /pmc/articles/PMC2375898/ /pubmed/18430208 http://dx.doi.org/10.1186/1471-2407-8-111 Text en Copyright © 2008 Robe et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Robe, Anne
Pic, Emilie
Lassalle, Henri-Pierre
Bezdetnaya, Lina
Guillemin, François
Marchal, Frédéric
Quantum dots in axillary lymph node mapping: Biodistribution study in healthy mice
title Quantum dots in axillary lymph node mapping: Biodistribution study in healthy mice
title_full Quantum dots in axillary lymph node mapping: Biodistribution study in healthy mice
title_fullStr Quantum dots in axillary lymph node mapping: Biodistribution study in healthy mice
title_full_unstemmed Quantum dots in axillary lymph node mapping: Biodistribution study in healthy mice
title_short Quantum dots in axillary lymph node mapping: Biodistribution study in healthy mice
title_sort quantum dots in axillary lymph node mapping: biodistribution study in healthy mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375898/
https://www.ncbi.nlm.nih.gov/pubmed/18430208
http://dx.doi.org/10.1186/1471-2407-8-111
work_keys_str_mv AT robeanne quantumdotsinaxillarylymphnodemappingbiodistributionstudyinhealthymice
AT picemilie quantumdotsinaxillarylymphnodemappingbiodistributionstudyinhealthymice
AT lassallehenripierre quantumdotsinaxillarylymphnodemappingbiodistributionstudyinhealthymice
AT bezdetnayalina quantumdotsinaxillarylymphnodemappingbiodistributionstudyinhealthymice
AT guilleminfrancois quantumdotsinaxillarylymphnodemappingbiodistributionstudyinhealthymice
AT marchalfrederic quantumdotsinaxillarylymphnodemappingbiodistributionstudyinhealthymice